Related Experiment Video
Updated: May 4, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Paracetamol: a focus for the general pediatrician.
Pierluigi Marzuillo1, Stefano Guarino, Egidio Barbi
1Department of Women and Children and General and Specialized Surgery, Seconda Università degli Studi di Napoli, Via L. De Crecchio 2, 80138, Naples, Italy, pierluigi.marzuillo@gmail.com.
Paracetamol (acetaminophen) is a common children's medication, but its optimal use for pain versus fever requires different administration strategies. Understanding its effects and toxicity risks is crucial for safe pediatric prescribing.
Area of Science:
- Pediatric pharmacology
- Pain and fever management
- Drug metabolism and toxicity
Background:
- Paracetamol (acetaminophen) is a widely used analgesic and antipyretic in children.
- Its precise pharmacodynamic mechanisms and effect compartment concentrations are not fully understood.
- Optimal dosing and administration routes may vary for pain versus fever management.
Purpose of the Study:
- To review paracetamol's mechanisms of action in pediatric patients.
- To highlight key pharmacodynamic concepts for clinical practice.
- To summarize risk factors for paracetamol toxicity at therapeutic doses.
Main Methods:
- Literature review of paracetamol's pharmacology and clinical use.
- Analysis of pharmacodynamic principles related to its effects.
- Identification of factors influencing paracetamol toxicity.
Main Results:
- The central nervous system is a primary site of paracetamol action.
- Rectal administration is effective for fever but not recommended for pain.
- Certain clinical conditions and concurrent medications can increase toxicity risk.
Conclusions:
- Pediatricians and general practitioners may lack familiarity with paracetamol's "effect compartment concentration" and toxicity co-factors.
- Optimizing paracetamol administration is essential to prevent overdose and maximize efficacy.
- N-acetyl-p-benzo-quinone imine (NAPQI) is the primary mediator of paracetamol-induced liver toxicity.
More Related Videos
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug Dosing: Infants and Children
Pharmaceutical Poisoning: Treatment Strategies

